Aminoglycosides, toxicity and cystic fibrosis.
Watson
Alan R
AR
University of Nottingham, Children & Young People's Kidney Unit, Nottingham University Hospitals, City Hospital Campus, Hucknall Road, Nottingham NG5 1PB, UK. judith.hayes@nuh.nhs.uk
D000328:Adult; D000617:Aminoglycosides / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D002442:Ceftazidime / Q000009:adverse effects; D002648:Child; D003550:Cystic Fibrosis / Q000188:drug therapy*; D005919:Glomerular Filtration Rate; D006207:Half-Life; D034381:Hearing Loss / Q000139:chemically induced*; D006801:Humans; D015994:Incidence; D007673:Kidney Cortex Necrosis / Q000139:chemically induced* / Q000503:physiopathology
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002442:Ceftazidime